A recent report published by Infinium Global Research on the parenteral nutrition market provides an in-depth analysis of segments and sub-segments in the global as well as regional parenteral nutrition market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional parenteral nutrition market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global parenteral nutrition market. According to the report, the global market for parenteral nutrition was sized USD 5.7 billion in 2020 and is expected to reach over USD 8.1 billion by 2026 growing with a CAGR of 5.8% over 2020-2026.

Market Insight

Parenteral nutrition refers to the intravenous administration of nutrient solutions to patients. It is a process by which liquid nutrients are inoculated into the body through the veins. Parenteral nutrition is generally used in a medical condition where a patient is not able to get sufficient nutrients through the food owing to the obstruction of the gastrointestinal tract. This leads to inadequate nourishment of the body. Furthermore, parenteral nutrition is typically designed for people suffering from Crohn’s disease, short bowel syndrome, and cancer. It aids to prevent malnutrition in patients who are unable to obtain adequate nutrients by oral or enteral routes. Nowadays, numerous commercial treatments and therapy are available in the markets which are used for different medical conditions. These commercially available premixed solutions efficiently provide nutrition for short periods, nevertheless in complex patients, personalizing parenteral nutrition is preferred.

An increase in the incidence of diseases that require parenteral nutrition such as gastrointestinal disorders, malnutrition, cancer, acquired immunodeficiency syndrome, etc. is the primary reason for the high growth of the parenteral nutrition market. Furthermore, the rise in the elderly population is another reason for market growth as this group is more prone to chronic diseases and needs more parenteral nutrition support in comparison to the young population. On the other hand, the shortage of skilled healthcare professionals and the risk of health complications owing to poor monitoring are hindering the growth of the parenteral nutrition market. However, rising technological innovation in parenteral therapy and growing demand for parenteral nutrition services around the globe with a significant rise in parenteral nutrition awareness is anticipated to offer lucrative opportunities for key players in the projection period.

Among the geographies, the North America region is expected to hold the largest share in the global parenteral nutrition market. The growth is owing to the presence of technologically advanced medical facilities, an increase in healthcare expenditure, and a growing geriatric population is anticipated to keep this region in the leading position during the prediction period. However, the Asia Pacific region is expected to witness the fastest growth in the parenteral nutrition market during the forecast period. Emerging economies such as India and China are accelerating the growth of this region due to favorable government initiatives towards the development of healthcare infrastructure and increased corporate investments in the healthcare sector are projected to augment the growth of the parenteral nutrition market over the forecast period.

Segment Covered

The report on the global parenteral nutrition market covers segments such as nutrient type, dosage form, and end-user. On the basis of nutrient type, the sub-markets include carbohydrates, amino acids, lipids, electrolytes, and others (multivitamin formulations and trace elements). On the basis of dosage form, the sub-markets include bags, vials, ampules, and bottles. On the basis of end-user, the sub-markets include clinics, hospitals, and others.

Companies Profiled:

The report provides profiles of the companies in the market such as B. Braun Melsungen AG, Fresenius Kabi AG, Allergan Plc, Grifols, S.A., Pfizer, Inc. (Hospira), Otsuka Pharmaceutical Factory, Inc., Baxter International, Inc., Sichuan Kelun Pharmaceutical Co., Ltd, Vifor Pharma, and Aculife (Nirlife).

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the parenteral nutrition market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.